WUXI BIOLOGICS CAYMAN INC USD00000083 144A REG S WXIBF
COM · Common Stock · CUSIP G97008117
0
institutional holders
-2 vs Q4 2021
—reported value*
0 new
0 added
0 reduced
2 sold out
net sold ≈ $98.6m (-8.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 1 |
| Q3 2021 | 1 |
| Q4 2021 | 2 |
| Q1 2022 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2021 | 1 | 0 |
| Q2 2021 | 0 | 1 |
| Q3 2021 | 0 | 1 |
| Q4 2021 | 1 | 1 |
| Q1 2022 | 0 | 2 |
Biggest buyers
| None |
Biggest sellers
| GILDER GAGNON HOWE & CO LLC | Sold out | -8.3m |
| Laird Norton Wetherby Trust Company, LLC | Sold out | -10.5k |
Holders, Q1 2022
| Manager | Shares | Change |
|---|